This is what Gen-1 is all about. One of the most promising long-term investment opportunities could be a cancer treatment known as immunotherapy, according to UBS's global chief investment officer.
"This emerging science offers the potential for attractive returns," said Mark Haefele, who oversees the investment policy and strategy for $2 trillion.
Immunotherapy is an increasingly popular cancer treatment that, roughly put, trains the body's immune system to aggressively attack cancerous cells that wouldn't ordinarily be recognized as threatening.
The immune system often overlooks cancer cells, but multiple types of immunotherapy have been developed in the past decade to address that.
Some treatments create proteins that bind to cancerous cells, marking them for the immune system. Another treatment involves extracting the white blood cells most active against tumors in the patient's body, and genetically modifying the cells to specifically attack cancerous ones.
'A hope they couldn't have fathomed'
The treatment came into focus just a few years ago, when clinical trials started showing promising results. In a 2013 test by Bristol-Myers Squibb, 22% of the 1,800 advanced melanoma patients treated with immunotherapy Yervoy were alive three years later.
"For physicians accustomed to losing every patient with advanced disease, the numbers bring a hope they couldn't have fathomed a few years ago," wrote Jennifer Couzin-Frankel for Science Magazine, after naming cancer immunotherapy as the breakthrough of 2013.
"The market for cancer treatments is expanding rapidly as populations age, and governments, insurers, and individuals are spending more on treatments that can extend life," Haefele said. "The spending per cancer patient rose by about 60% between 2010 and 2014 in the US, Germany, and Canada."
For many, the promising technique could offer another chance for patients who have exhausted traditional options. The rest of article on reply.
Sentiment: Strong Buy
Yeah, excited about tomorrow. Great to see it making a move without news. Will make it that much better when we actually get news.
Word spreading in Tel Aviv can only help our situation. Look for another positive move Friday even though the market closes at 1pm.
Sentiment: Strong Buy
CLSN Dual-Listed Company
Security Type : Share
[Add Security to My TASE]
Closing Price (0.01 NIS)
Change(%) + 4.83%
The same symbol as at home
You really need to do a google or yahoo search for "Penny Stock 101 org' and signup for their 100% complimentary email newsletter. They consistently bring me winning trade ideas. Just 8 ½ weeks into the 'Fall 2015' season and they've put out a combined total of +1,843% in profit. I am very impressed! Try it out for yourself now